Effective 28 November 2017, the Centers for Medicare & Medicaid Services (CMS) mandated long-term care facilities (LTCFs) to have antimicrobial stewardship programs (ASPs) in place. Although guidance exists for establishing ASPs in LTCFs, limited data exist on the "how. " As comprehensive ASPs already exist in many acute-care hospitals (ACHs) and with the known "sharing of patients" between both settings, extending ACH ASP expertise to LTCFs will not only aid LTCFs in complying with the CMS mandate but will likely also facilitate in decreasing multidrug-resistant organisms and Clostridium difficile infection rates in patients at both organizations. Here, we provide a roadmap on how to implement ASPs in LTCFs, using examples from our own ACH's collaboration with local LTCFs to develop and sustain LTCF ASPs. We discuss critical elements to achieving successful LTCF ASPs, including the potential barriers and how to overcome them.
presented to ACH leadership in the context of existing quality and safety efforts and the need for a regional strategy among a shared patient population. The engagement of the local health department can be critical to fostering this partnership.
We undertook an outreach effort and collaborated with local nonaffiliated LTCFs. An existing voluntary collaboration (Enhanced Care Program) between our ACH and local LTCFs was successful in reducing hospital readmissions, establishing close administrative ties, and creating a foundation for additional collaboration [11] . As the LTCFs did not have personnel and expertise to initiate AMS interventions, ACH clinical professionals provided the clinical ID, epidemiology and antibiotic pharmacy expertise, education, tools, and consultation to establish these basic AMS processes. Our aim was to ultimately transition ASP oversight to the respective LTCF's quality improvement (QI) committees, while offering ongoing consultative support from our hospital-based epidemiology and stewardship team. This type of intervention has been shown to be effective. Rahme et al reported that a hospital-based ASP intervention at a local LTCF resulted in a 17% decrease in overall fluoroquinolone use and 20% reduction in CDI rates [12] .
Other approaches to promote interfacility collaboration have been described. Some ACHs have adopted a "preferred" status list of exclusive LTCFs recommended to patients after discharge, encouraging LTCFs to comply with CMS regulations. Creation of these preferred networks is a novel strategy for ACHs to ultimately improve transitions and quality of care for patients at LTCFs. As an example, Hoag Memorial Hospital Presbyterian (Newport Beach, California) released a request for proposals to neighboring LTCFs; applications were reviewed by a committee (consisting of a hospitalist/physician lead of readmission reduction, director of care management, director of performance improvement, and regional director of LTCFs); and 7 LTCFs were ultimately selected as preferred based on various outcome variables from state health reports and Medicare quality measures, as well as questionnaires and interviews from Hoag and the facilities (Robinson P, Hoag Memorial Hospital Presbyterian, oral personal communication; 16 October 2017) . The preferred LTCFs have seen a reduction in fluoroquinoline use, CDIs, and inappropriate urine culture ordering. Similarly, Banner Health (Phoenix, Arizona) demonstrated that patients sent to preferred facilities had 5-7 shorter lengths of stay compared to those sent to nonpreferred facilities [13] .
Gain Leadership Commitment and Accountability From LTCFs
Engaging LTCF leaders is crucial to ensure agreement on the value for the AMS collaboration. As highlighted in the Joint Commission AMS standards, the IDSA/SHEA ASP guidelines, and by the Centers for Disease Control and Prevention (CDC), leadership commitment is vital for any ASP to succeed [2, 8, 14] . Therefore, building a solid foundation of key LTCF stakeholders, including the administrator, medical director, director of staff development (DSD), and director of nursing (DON), and holding each other accountable for various components of a stewardship program (ie, education, monitoring, data review) are important. Leadership commitment from these LTCF stakeholders can be gained by first outlining a case for collaboration that included the following: the regulatory mandate for ASP in LTCFs; the opportunity to align quality and safety efforts related to ASP as well as HAI and MDRO prevention; the ready access to ID and ASP expertise and educational resources from the ACH with relatively little resource allocation required from the LTCF; and support extended from the local public health department. The benefits of a regional strategy among a shared patient population can be presented as a win-win not only for the patients but also for the facilities involved. Partnering with an ACH may also provide LTCFs with more stability and continuity in sustaining the programs with shared accountability with the ACH, especially if there are many transfers between facilities. Establishment of such a collaboration includes agreement to hold regular meetings with multidisciplinary stakeholders, periodic sharing of key process and outcome data (eg, reviewing the antibiogram, MDRO trends, antibiotic utilization), and feedback on sustainability of the ASP. Communication of this information should occur via consultation, lectures and in-services, meetings with LTCF leadership, and onsite visits with key staff.
As education is the foundation of ASPs, the DSD is key in leading these educational initiatives. We gained support from the DSDs to organize in-services for nursing staff on the basics of AMS and its importance, appropriate management of certain disease states (ie, urinary tract infections [UTIs], including appropriate urine collection and ordering of cultures), interpreting the antibiogram, disease-based guidelines, and consequences of antibiotic use. An ASP physician and pharmacist and ID fellow from our ACH created and delivered these in-services to nursing staff, physicians, and nonphysician practitioners (physician assistants and nurse practitioners). We also leveraged support from the local public health department (Los Angeles County Acute Communicable Diseases Unit), which contributed resources and public health expertise to support the effort, including staff to assist with clinical chart review, content development, and printing educational posters.
With high staff turnover prevalent in LTCFs, it is vital for the DON, medical director, and administrator to cultivate an environment of nurse empowerment [15] . The DON and administrator, who report directly to the chief executive officer or board of directors as necessary, should be the primary communicators between the nursing staff and physicians and nonphysician practitioners and between patients and physicians and nonphysician practitioners. Nurses and the DON are typically the driving force in developing and implementing the ASP policy. A nursing ASP champion, typically the DON or a licensed nurse already involved in the infection prevention program for the LTCF, should be identified to lead AMS initiatives.
Equally critical to designating a nursing AMS champion, a physician or nonphysician practitioner champion should also be identified. Accordingly, the medical director's key responsibilities should be focused on championing standards for antibiotic practices, including appropriately and accurately documenting dose, duration, route, and indication of antibiotic therapy, for all physicians and nonphysician practitioners. In our experience, a successful ASP emerged when the medical director and DON established a strong collaborative relationship with good communication. Medical directors should also take the lead in overseeing adherence to antibiotic prescribing practices and holding individual clinicians accountable if they are not followed. A recent study of approximately 250 primary care physicians found that the use of accountable justification and peer comparison as behavioral interventions resulted in lower rates of inappropriate antibiotic prescribing for acute respiratory tract infections (ARTIs) [16] . Therefore, we recommend that medical directors provide regular feedback on antibiotic prescribing, both at the facility and individual prescriber levels [14] . Public commitment from clinicians has also been shown to have a positive impact on appropriate antibiotic usage. Meeker et al found a 20% reduction in unnecessary antibiotic usage rates for patients treated by clinicians who signed and posted a letter, featuring clinicians' photographs and signatures, in their examination rooms, emphasizing a commitment to avoid inappropriate antibiotic prescribing for ARTIs [16] . Social psychology research suggests that those who make public commitments to specific behaviors are more likely to follow through with those pledges [17] . Various free educational resources, including commitment posters, are available for clinicians (Table 3) [7, 8, [18] [19] [20] [21] [22] .
Gain Commitment From Other Personnel in LTCFs

Nursing Staff
Registered nurses and licensed vocational nurses are the predominant driving force behind AMS and monitoring of antibiotic use in LTCFs. They assess and care for patients and serve as the primary communicators among patients, family, other LTCF staff, and physicians and nonphysician practitioners. Nurses have always performed various functions essential to successful AMS in all healthcare settings [23] . They recognize, assess, and monitor patients with infections and are often the only licensed healthcare professionals available on site 24 hours a day [24] . Treating physicians and nonphysician practitioners are typically off site and may spend <2 hours/ week at an LTCF [25] . Consequently, they make most of their antibiotic decisions via brief telephone interactions with nursing staff and depend heavily on patients' assessment information communicated by nurses. A study from a Cleveland LTCF reported that physicians often ordered antibiotics for UTIs without seeing the patients and relied on nurses to provide information regarding the signs and symptoms of UTIs [26] . Despite this reliance on nurses, many nurses do not have adequate training on patient evaluation for a possible infection. Olans and colleagues illustrated that among 900 publications on AMS, only 11 appeared in nursing journals, signifying the lack of literature available to nurses on AMS [27] . Additionally, in a survey to more than 900 nursing staff and midwives, only 36% classified their stewardship knowledge as "very good" or "good," and only 21% were familiar with the term "AMS" [28] . Due to this lack of knowledge, nurses are reluctant to challenge a prescriber's orders.
Nursing-specific education on appropriate assessment and management strategies for infections should be provided to elevate their clinical knowledge related to AMS and to effectively leverage their role in patient care. The nursing community has acknowledged that a "disruptive" change must occur within nursing education and practice, where old traditions of nurses' passive role in healthcare must be relinquished and new forward thinking of nurses serving as leaders integrated into the clinical-decision making team must be embraced [29] . As there is inadequate science content, particularly no microbiology course requirement, in nursing curricula, leading to nurses' lack of comfort in foundational knowledge related to patient care; this type of education needs to be incorporated in nursing schools as problem-based learning [30] . Accordingly, the American Nurses Association in partnership with the CDC released a White Paper outlining nurses' role in AMS efforts [19] .
For nursing staff currently working in LTCFs, Wilson et al developed an educational bundle to nursing staff in LTCFs that consists of a free online course with 6 interactive modules about ID, sample collection, and communication. After the course, nurses' agreement that their role influences whether patients receive antibiotics increased significantly in addition to their overall confidence [31] . We recommend incorporating AMS education into orientation for all new nursing staff since LTCF staff turnover is high and also integrating regular (at least quarterly) educational sessions (via in-services, employee newsletters, online modules) on AMS and resistance with particular focus on interventions [15] . The advantage of collaboration with an ACH is the availability of ACH staff to provide training tailored to the needs of the nursing staff at individual LTCFs, providing real-time or retrospective chart reviews, and identifying further educational opportunities on an ongoing basis. 
Patients and Family
Just as important as education to LTCF staff is education to patients and their families as patient-and family-perceived expectations on antibiotic treatment play a significant role in clinical management in LTCFs [32] . In a survey conducted in Nebraska LTCFs, patient and family expectations were cited in 15% of the cases as a potential barrier to ASPs [33] . We, therefore, recommend engaging patients and family in the clinical decision process, where benefits and risks of antibiotics are discussed. Education to LTCF patients and families is an element of the CDC's stewardship checklist, and free educational material is available online [7] . Visible posters about safe and effective use of antibiotics displayed in visitor areas and patient rooms (available on the CDC website) can serve as an educational tool [14] . Additionally, displaying commitment posters in patients' rooms will keep patients and their family members more educated about appropriate antibiotic usage, make them more likely to support the clinician's commitment to this pledge, and may make them less likely to expect or demand antibiotics from their clinician [16] .
Consultant Laboratory
Many LTCFs do not have onsite microbiology laboratories, potentially delaying the reporting of culture and susceptibility results. Therefore, it is crucial for LTCFs to develop a strong relationship with the consultant laboratory to obtain yearly antibiograms, which all clinicians should be educated on, and timely diagnostic information. As many LTCFs may not have ready access to ID expertise, the benefits of an ACH team's assessment of the antibiogram and review of antibiotic treatment protocols are likely to be appreciated.
Consultant Pharmacist
The consultant pharmacist, who is off site in LTCFs, should be a key individual who delivers in-services on various antibiotic-related topics and performs data analysis on antibiotic utilization, appropriate laboratory testing, and yearly antibiogram updates, which should be presented at QI meetings. Data generation is imperative as it establishes the progress and existing gaps of ongoing AMS initiatives; engaging the DSD can be helpful in this endeavor. Traditional measures such as overall days of therapy or antimicrobial utilization costs may be challenging to calculate in LTCFs, where data may be manually collected, decentralized, or not collected at all. Clinical outcome measures such as CDI rates, antimicrobial resistance trends, and hospital admissions are often confounded by other factors and do not adequately reflect stewardship efforts. In our experience, the ACH ASP pharmacist and consultant pharmacist provided metrics to the LTCFs such as the frequency of antibiotic prescriptions for various indications, fluoroquinolone use, and compliance with LTCF-specific protocols. A longitudinal approach in ACHs and
LTCFs is needed to coordinate inpatient and post-discharge care and medication management. We recommend ASP metrics be incorporated into QI committees, with at least quarterly feedback provided to LTCF clinical staff, physicians and nonphysician practitioners, and administrative leaders by the ACH ASP pharmacist and/or consultant pharmacist.
Determine Baseline AMS Dynamics
Once AMS priority has been established among LTCFs, conducting a questionnaire with DONs will serve as a baseline assessment of the facility's AMS capacity and establish opportunities and identify barriers. A baseline questionnaire, which we adapted from Van Schooneveld et al, is provided in Table 4 [33]. These questions focused on assessing existing AMS tools that promote appropriate antibiotic use (ie, education, disease-specific guidelines), microbiology and resistance patterns, and information systems in place. We used this survey combined with face-to-face site visits to expand on survey responses in our collaboration to determine priorities, which were identified as staff educational needs and treatment of UTIs (distinguishing between colonization and infection) as a focus for an ASP QI project.
Despite clear guidelines that antibiotic treatment of asymptomatic bacteriuria is not needed and actually harmful, overtreatment remains common in LTCF patients, likely due to ambiguous clinical criteria for symptomatic UTIs including altered mental status, malaise, lethargy, and pelvic discomfort [6, 34, 35] . Written checklists that guide clinical assessment based on established criteria (such as the revised McGeer criteria) can be used to guide diagnosis and appropriate treatment [36] .
Accordingly, in our QI initiative, we did the following: (1) discovered that approximately 70% of patients were being treated for asymptomatic bacteriuria, partly due to inappropriate urine culture ordering. Positive cultures (ie, urine, skin) often serve as a trigger for initiation of inappropriate antibiotic prescribing in the absence of symptoms; 2) recommended instituting a "urinalysis with reflex to urine culture and sensitivity, if indicated" rather than the standard order for "urine culture and sensitivity. " The laboratory would, in effect, only process urine cultures if criteria were met for abnormal urinalyses, thereby decreasing the number of urine cultures performed while avoiding delay at the facility; 3) obtained antibiograms from LTCF-affiliated microbiology laboratories, evaluated the LTCF antibiograms, and developed UTI treatment guidelines for each facility; 4) trained nurses to use situation, background, assessment, and recommendation (SBAR) forms as a "script" in communicating effectively with physicians and nonphysician practitioners in a manner that encourages guideline-concordant management; 5) educated nurses, physicians, and nonphysician practitioners through in-services and QI meetings on the distinction between colonization and infection, appropriate urine culture ordering, 
CONCLUSIONS
With the sharing of patients and transmission of AMR infections between ACHs and LTCFs, urgent measures are needed to implement ASPs in LTCFs. The existing lack of care coordination between hospitals and LTCFs around discharged patients is not only costly to Medicare but also to patients. Extending ACH AMS expertise to neighboring LTCFs will enable both organizations to work toward the common goal of delivering safe and high-quality care throughout the healthcare continuum.
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